{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:47:38Z","timestamp":1793260058813,"version":"4.5.0"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Patients with type O blood may have an increased risk of hemorrhagic complications because of lower baseline levels of von Willebrand factor and factor VIII, but the transition to a mortality difference in trauma is less clear. We hypothesized that type O trauma patients will have differential proteomic and metabolomic signatures in response to trauma beyond von Willebrand factor and factor VIII alone.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>Patients meeting the highest level of trauma activation criteria were prospectively enrolled. Blood samples were collected upon arrival to the emergency department. Proteomic and metabolomic (multiomics) analyses of these samples were performed using liquid chromatography\u2013mass spectrometry. Demographic, clinical, and multiomics data were compared between patients with type O blood versus all other patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>There were 288 patients with multiomics data; 146 (51%) had type O blood. Demographics, injury patterns, and initial vital signs and laboratory measurements were not different between groups. Type O patients had increased lengths of stay (7 vs. 6 days, <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.041) and a trend toward decreased mortality secondary to traumatic brain injury compared with other causes (traumatic brain injury, 44.4% vs. 87.5%; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.055). Type O patients had decreased levels of mannose-binding lectin and mannose-binding lectin\u2013associated serine proteases 1 and 2, which are required for the initiation of the lectin pathway of complement activation. Type O patients also had metabolite differences signifying energy metabolism and mitochondrial dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Blood type O patients have a unique multiomics signature, including decreased levels of proteins required to activate the lectin complement pathway. This may lead to overall decreased levels of complement activation and decreased systemic inflammation in the acute phase, possibly leading to a survival advantage, especially in traumatic brain injury. However, this may later impair healing. Future work will need to confirm these associations, and animal studies are needed to test therapeutic targets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>LEVEL OF EVIDENCE<\/jats:title>\n            <jats:p>Prognostic and Epidemiological; Level IV.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ta.0000000000004367","type":"journal-article","created":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T01:02:12Z","timestamp":1715734932000},"page":"753-763","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Trauma patients with type O blood exhibit unique multiomics signature with decreased lectin pathway of complement levels"],"prefix":"10.1097","volume":"97","author":[{"given":"Benjamin W.","family":"Stocker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian S.","family":"LaCroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren T.","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Ramser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto","family":"Thielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Hallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanchayita","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest E.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"D'Alessandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Silliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell J.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5,15]]},"reference":[{"issue":"5","key":"bib1-20250806","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1537-2995.2004.03338.x","article-title":"ABO and Rh(D) phenotype frequencies of different racial\/ethnic groups in the United States","volume":"44","year":"2004","journal-title":"Transfusion"},{"issue":"6","key":"bib2-20250806","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","year":"1987","journal-title":"Blood"},{"key":"bib3-20250806","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-9560-5-14","article-title":"Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications","volume":"5","year":"2007","journal-title":"Thromb J"},{"issue":"1","key":"bib4-20250806","first-page":"89","article-title":"Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level","volume":"37","year":"1985","journal-title":"Am J Hum Genet"},{"issue":"25","key":"bib5-20250806","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood.2020005843","article-title":"The relationship between ABO blood group, von Willebrand factor, and primary hemostasis","volume":"136","year":"2020","journal-title":"Blood"},{"issue":"10","key":"bib6-20250806","first-page":"1","article-title":"Deaths: final data for 2020","volume":"72","year":"2023","journal-title":"Natl Vital Stat Rep"},{"issue":"2","key":"bib7-20250806","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/00005373-199502000-00006","article-title":"Epidemiology of trauma deaths: a reassessment","volume":"38","year":"1995","journal-title":"J Trauma"},{"issue":"Suppl 2(Suppl 2)","key":"bib8-20250806","first-page":"s3","article-title":"Role of von Willebrand factor in the haemostasis","volume":"9","year":"2011","journal-title":"Blood Transfus"},{"issue":"1","key":"bib9-20250806","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0032-1329550","article-title":"Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis","volume":"39","year":"2013","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"bib10-20250806","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/SHK.0000000000002013","article-title":"Blood type O is a risk factor for hyperfibrinolysis and massive transfusion after severe injury","volume":"58","year":"2022","journal-title":"Shock"},{"issue":"2","key":"bib11-20250806","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/SHK.0000000000001497","article-title":"The association between ABO blood type and mortality among severely injured trauma patients","volume":"54","year":"2020","journal-title":"Shock"},{"issue":"4","key":"bib12-20250806","first-page":"8214","article-title":"The influence of ABO blood group on mortality in major trauma","volume":"11","year":"2019","journal-title":"Orthop Rev (Pavia)"},{"issue":"2","key":"bib13-20250806","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/IJCIIS.IJCIIS_83_20","article-title":"The association of ABO blood groups and trauma outcomes: a retrospective analysis of 3779 patients","volume":"11","year":"2021","journal-title":"Int J Crit Illn Inj Sci"},{"issue":"1","key":"bib14-20250806","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13054-018-2022-0","article-title":"The impact of blood type O on mortality of severe trauma patients: a retrospective observational study","volume":"22","year":"2018","journal-title":"Crit Care"},{"issue":"1","key":"bib15-20250806","doi-asserted-by":"crossref","first-page":"16147","DOI":"10.1038\/s41598-021-95443-3","article-title":"The impact of blood type on the mortality of patients with severe abdominal trauma: a multicenter observational study","volume":"11","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"bib16-20250806","first-page":"978","article-title":"Type-O blood is not associated with elevated mortality after trauma: a north American cohort study","volume":"90","year":"2023","journal-title":"Am Surg"},{"issue":"2","key":"bib17-20250806","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/WNR.0b013e32835c93a2","article-title":"ABO blood antigens define human cerebral endothelial diversity","volume":"24","year":"2013","journal-title":"Neuroreport"},{"issue":"1","key":"bib18-20250806","doi-asserted-by":"crossref","first-page":"e144075","DOI":"10.1172\/JCI144075","article-title":"ABO blood type: a window into the genetics of acute respiratory distress syndrome susceptibility","volume":"131","year":"2021","journal-title":"J Clin Invest"},{"issue":"4","key":"bib19-20250806","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood.V96.4.1574","article-title":"Blood group a and B antigens are strongly expressed on platelets of some individuals","volume":"96","year":"2000","journal-title":"Blood"},{"issue":"6","key":"bib20-20250806","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/wsbm.1355","article-title":"Blood type biochemistry and human disease","volume":"8","year":"2016","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"3","key":"bib21-20250806","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.surg.2018.04.029","article-title":"Rapid TEG efficiently guides hemostatic resuscitation in trauma patients","volume":"164","year":"2018","journal-title":"Surgery"},{"issue":"8","key":"bib22-20250806","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/trf.17472","article-title":"Omics markers of platelet transfusion in trauma patients","volume":"63","year":"2023","journal-title":"Transfusion"},{"key":"bib23-20250806","first-page":"13","article-title":"High-throughput metabolomics: isocratic and gradient mass spectrometry-based methods","volume":"2019","year":"1978","journal-title":"Methods Mol Biol"},{"issue":"W1","key":"bib24-20250806","doi-asserted-by":"crossref","first-page":"W388","DOI":"10.1093\/nar\/gkab382","article-title":"MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights","volume":"49","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"bib25-20250806","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1556\/EuJMI.2.2012.2.2","article-title":"The complement system: history, pathways, cascade and inhibitors","volume":"2","year":"2012","journal-title":"Eur J Microbiol Immunol (Bp)"},{"issue":"13","key":"bib26-20250806","doi-asserted-by":"crossref","first-page":"6836","DOI":"10.3390\/ijms22136836","article-title":"Annexin A2 in fibrinolysis, inflammation and fibrosis","volume":"22","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"bib27-20250806","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/ATVBAHA.111.226845","article-title":"Regulation of neutrophil function by adenosine","volume":"32","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"bib28-20250806","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.RES.0000250174.31269.70","article-title":"ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function","volume":"99","year":"2006","journal-title":"Circ Res"},{"key":"bib29-20250806","doi-asserted-by":"crossref","first-page":"936547","DOI":"10.3389\/fimmu.2022.936547","article-title":"The immunomodulatory function of adenosine in sepsis","volume":"13","year":"2022","journal-title":"Front Immunol"},{"issue":"2","key":"bib30-20250806","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1172\/JCI114213","article-title":"The erythrocyte as instigator of inflammation. Generation of amidated C3 by erythrocyte adenosine deaminase","volume":"84","year":"1989","journal-title":"J Clin Invest"},{"key":"bib31-20250806","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3389\/fimmu.2018.01295","article-title":"The emerging link between the complement cascade and purinergic signaling in stress hematopoiesis","volume":"9","year":"2018","journal-title":"Front Immunol"},{"issue":"12","key":"bib33-20250806","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/00003246-199712000-00019","article-title":"Circulating complement proteins in multiple trauma patients\u2014correlation with injury severity, development of sepsis, and outcome","volume":"25","year":"1997","journal-title":"Crit Care Med"},{"issue":"1","key":"bib34-20250806","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/shk.0b013e3180342439","article-title":"Role of the alternative pathway in the early complement activation following major trauma","volume":"28","year":"2007","journal-title":"Shock"},{"issue":"5","key":"bib35-20250806","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/TA.0000000000003713","article-title":"Postinjury complement C4 activation is associated with adverse outcomes and is potentially influenced by plasma resuscitation","volume":"93","year":"2022","journal-title":"J Trauma Acute Care Surg"},{"issue":"10","key":"bib36-20250806","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.4049\/jimmunol.174.10.6373","article-title":"Gastrointestinal ischemia-reperfusion injury is lectin complement pathway dependent without involving C1q","volume":"174","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"bib37-20250806","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4049\/jimmunol.1500793","article-title":"Annexin A2 enhances complement activation by inhibiting factor H","volume":"196","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"bib38-20250806","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12974-018-1066-z","article-title":"The role of the complement system in traumatic brain injury: a review","volume":"15","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"3","key":"bib39-20250806","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3171\/jns.1996.85.3.0468","article-title":"Activation of the complement cascade and increase of clusterin in the brain following a cortical contusion in the adult rat","volume":"85","year":"1996","journal-title":"J Neurosurg"},{"issue":"12","key":"bib40-20250806","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/08977150152725605","article-title":"Complement activation in the human brain after traumatic head injury","volume":"18","year":"2001","journal-title":"J Neurotrauma"},{"issue":"8","key":"bib41-20250806","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/CCM.0000000000000399","article-title":"Mannose-binding lectin is expressed after clinical and experimental traumatic brain injury and its deletion is protective","volume":"42","year":"2014","journal-title":"Crit Care Med"},{"issue":"1","key":"bib42-20250806","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TA.0000000000002092","article-title":"Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner","volume":"86","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"8","key":"bib43-20250806","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/MBC.0000000000000938","article-title":"Tranexamic acid is associated with reduced complement activation in trauma patients with hemorrhagic shock and hyperfibrinolysis on thromboelastography","volume":"31","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"4","key":"bib44-20250806","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0049-3848(89)90317-4","article-title":"von Willebrand factor is an acute phase reactant in man","volume":"53","year":"1989","journal-title":"Thromb Res"},{"issue":"3","key":"bib45-20250806","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/jth.13208","article-title":"The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation","volume":"14","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"4","key":"bib46-20250806","doi-asserted-by":"crossref","first-page":"e35690","DOI":"10.1371\/journal.pone.0035690","article-title":"Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation","volume":"7","year":"2012","journal-title":"PloS One"},{"issue":"3","key":"bib47-20250806","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","article-title":"The role of complement in inflammatory diseases from behind the scenes into the spotlight","volume":"171","year":"2007","journal-title":"Am J Pathol"},{"issue":"2","key":"bib48-20250806","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1124\/pharmrev.120.000072","article-title":"Therapeutic targeting of the complement system: from rare diseases to pandemics","volume":"73","year":"2021","journal-title":"Pharmacol Rev"},{"issue":"1","key":"bib49-20250806","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.smim.2013.05.006","article-title":"The role of complement in trauma and fracture healing","volume":"25","year":"2013","journal-title":"Semin Immunol"},{"issue":"5","key":"bib50-20250806","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/SHK.0000000000000948","article-title":"The Metabolopathy of tissue injury, hemorrhagic shock, and resuscitation in a rat model","volume":"49","year":"2018","journal-title":"Shock"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:00:57Z","timestamp":1754496057000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000004367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000004367","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,15]]}}}